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ABSTRACT 
Objective: To analyze the Barrow Neurological Institute (BNI) grading scale, a 
quantitative scale measuring maximal subarachnoid hemorrhage thickness on axial 
computed tomography, on delayed cerebral ischemia (DCI) and outcome (modified 
Rankin scale; mRS) at discharge and 1-year follow-up (1FU) in patients with 
aneurysmal subarachnoid hemorrhage (aSAH) from a nationwide SAH registry.     
Methods All patient data was obtained from the Swiss nationwide multicentre 
registry database of aSAH (Swiss SOS). In 1321 patients demographic data, BNI 
scale, DCI and mRS up to the 1FU were available for descriptive and univariate 
statistics. Outcome was dichotomized in favorable (mRS 0-2) and unfavorable (mRS 
3-6). Odds ratios (OR) for DCI of Fisher 3 patients (n=1115, 84%) compared to a 
control cohort of Fisher grade 1,2 and 4 patients (n=206, 16%) were calculated for 
each BNI grade separately. 
Results Overall, 409 patients (31 %) developed DCI with a high DCI rate in the 
Fisher 3 cohort (34%). For what concerns the BNI scale, DCI rates went up 
progressively from 26% (BNI 2) to 38% (BNI 5) and corresponding OR for DCI 
increased from 1.9 [1.0 – 3.5, 95 % CI] to 3.4 [2.1 – 5.3], respectively. BNI grade 5 
patients had high rates of unfavorable outcome with 75% at discharge and 58% at 
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1FU. The likelihood for unfavorable outcome was high in BNI grade 5 patients with 
OR 5.9 [3.9 – 8.9] at discharge and OR 6.6 [4.1 – 10.5] at 1FU. 
Discussion This multicenter external validation analysis from a prospective 
nationwide patient registry confirms that patients with a higher BNI grade show a 
significantly higher risk for DCI. The BNI grade was also a predictor for unfavorable 
outcome at discharge and at 1FU. 
 
INTRODUCTION 
Previous data indicate that the amount of subarachnoid blood in aneurysmal 
subarachnoid hemorrhage (aSAH) correlates with the incidence of delayed cerebral 
ischemia (DCI).1-6 The most commonly used grading scales to predict vasospasm or 
DCI in aSAH are the Fisher or the modified Fisher scales, which account for the 
blood extension in the subarachnoid space as well as for presence of intraventricular 
or –cerebral hemorrhage.1,4 Recently, a relatively simple grading scale – the so 
called Barrow Neurological Institute (BNI) grading scale – focusing on the prediction 
of symptomatic vasospasm based on the maximal clot thickness in any cistern or 
fissure was published.7 Despite being simpler to apply than the previously 
established (modified) Fisher scales, the BNI scale could predict symptomatic 
vasospasm more accurately in the initial single center analysis. The findings were 
recently confirmed by an external single-center validation.8 
To confirm that the findings of the BNI grading scale are universally valid, a 
multicenter external validation is still needed and was performed in this study. With 
our prospectively collected Swiss nationwide aSAH registry (Swiss SOS) we have 
the unique opportunity to validate the BNI grading scale in a large, unselected and 
multi-cultural cohort. 
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PATIENTS AND METHODS 
Patients and inclusion criteria 
All anonymous patient data was obtained from the prospective Swiss 
nationwide multicenter registry for aSAH (Swiss SOS; http://swiss-sos.ch; IRB No 11-
233R (NAC 11-085R)) and was approved by the local ethical committee from Zurich 
(54-2015).9 All patients with a complete dataset including a CT/CTA at admission to 
analyse the BNI grade (n=1321) were included for this analysis. Anonymous patient 
data from the following neurosurgical centers were analysed: Aarau, Basel, Bern, 
Geneva, Lausanne, Lugano, St. Gallen and Zurich.  
 
Clinical and radiological patient data 
Age, gender, WFNS grade, Fisher grade and outcome at discharge and 1-year 
follow-up (1FU) using the modified Rankin Scale (mRS) were used for analysis. 
Clinical outcome was dichotomized into favorable (mRS 0-2) and unfavorable (mRS 
3-6). In addition, each center collected radiographic data to calculate the BNI grade 
based on CT scans at admission. The BNI grade according to the original publication 
was based on a single measurement of the maximal clot thickness in any cistern or 
fissure.7 The measurement was made perpendicular to the direction of the 
cistern/fissure and in case of multiple measurements, only the largest measurement 
was used. Clinical deterioration attributable to delayed cerebral ischemia (DCI) was 
defined according to Vergouwen et al. as a delayed decrease of consciousness by at 
least 2 points on the Glasgow Coma Scale (GCS) and/or a new focal neurological 
deficit, after ruling out other causes.10  
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Statistical testing 
Statistical analysis was performed using SPSS 20 (IBM, Chicago, IL, USA) 
and figures were generated using Microsoft Excel (Microsoft Corporation, Redmont, 
WA, USA). Continuous variables are presented as mean with standard error of the 
mean. Comparisons between groups were performed using the Mann-Whitney-U test 
for continuous parameters and the Chi-square test or the Fisher`s exact test for 
categorical parameters. Statistical significance was established at the alpha level of p 
= 0.05. The performance of the BNI scale, the WFNS score, a new combined score 
including BNI, WFNS and patient age was evaluated by comparing the areas under 
the receiver-operating characteristic curves (AUROCs). An AUROC of 0.5 indicates 
no discrimination, whereas an AUROC of 1 indicates perfect discrimination. 
 
RESULTS 
Overall, 1321 patients were included in this study (468 males, 853 females). 
Median age was 55 years (IQR, 47 – 65). The rate of high-grade aSAH (WFNS 
grades 4 and 5) was high with 37.9 % (500/1321). The majority of patients belonged 
to the Fisher 3 cohort (1115, 84.4 %). Details of the patient characteristics as well as 
the BNI grading, the WNFS and the Fisher grading are depicted in Figure 1 as well 
as in Table 1. 
  
BNI grading and DCI rates 
Overall, 402 (31.0 %) patients developed DCI. Specific DCI rates for WFNS 
grade, Fisher grade and BNI grade are depicted in Figure 2 and patient 
characteristics of patients that developed DCI and those without are shown in Table 
1. Patients with a Fisher grade of 3 were by far the largest group with 1115 of 1321 
patients (84.4 %). As expected, the DCI rate was high in the Fisher 3 cohort with 
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377/1115 (33.8 %). In order to sub-stratify DCI risks within this large cohort of Fisher 
3 patients, the odds ratios (OR) for DCI of Fisher 3 patients (n=1115, 84.4 %) 
compared to a control cohort of Fisher grade 1, 2 and 4 patients (n=206, 15.6 %) 
were calculated for each BNI grade separately (Table 2). BNI grade 1 patients (no 
visible SAH) were by definition not part of the Fisher 3 cohort and were therefore not 
included in this comparison. DCI rates went up from 25.6 % (BNI 2) to 38.2 % (BNI 5) 
with corresponding OR of 1.9 [1.0 – 3.5, 95 % CI] and 3.4 [2.1 – 5.3, 95 % CI], 
respectively. 
 
BNI grading and clinical outcome 
Outcome was dichotomized in favorable (mRS 0-2) and unfavorable (mRS 3-
6) and assessed at two time points: at discharge (data of 1298 patients available) 
and at 1FU (data of 1119 patients available). Again, clinical outcome of Fisher 3 
patients were compared to Fisher grade 1, 2 and 4 and ORs were calculated for each 
BNI grade. Outcome data at discharge is depicted in Table 3 and outcome at 1FU is 
shown in Table 4. Non-aggregated mRS data is shown for both time points and each 
BNI grade in Figure 3. Of note, BNI grade 5 patients had high rates of unfavorable 
outcome with 74.9 % at discharge and 57.9 % at 1FU. Correspondingly, ORs were 
high with OR 5.9 [3.9 – 8.9, 95 % CI] at discharge and OR 6.6 [4.1 – 10.5, 95 % CI] 
at 1FU. The effect sizes of the influence of high grade BNI on unfavorable outcome 
were more pronounced than the effect sizes of the influence of high grade BNI on 
DCI. 
Based on AUROC (Figure 4 A) the BNI scale showed a significantly lower 
area under the curve (AUC) (0.663) and therefore a lower prediction of favorable 
patient outcome (mRS 0-2) at discharge compared to the WFNS score (0.734). A 
new score based on the BNI scale, WFNS score and patient age (Figure 4 B) 
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showed a higher AUC (0.768; p<0.0001). There was hence a better discrimination of 
clinical outcome possible when adding information of the BNI score to the WFNS-
score based outcome prediction model.  
 
DISCUSSION 
In this external validation analysis from a prospective multicenter patient 
registry in Switzerland (Swiss SOS) we were able to confirm that patients with a 
higher BNI grade showed a significantly higher risk for DCI. In addition, we 
demonstrated that the BNI grading system is useful to predict unfavorable outcome 
at discharge and at 1FU.  
This is an important finding, since previously published results were only 
based on single institution data sets with small patient numbers, less accurate point 
estimates and relatively large confidence intervals. In this respect, it must be pointed 
out that previous results were not universally valid.7,8 The Swiss SOS data spans 
over eight neurovascular centers, combines four linguistic areas in Switzerland 
(German, French, Italian, Romansh language) and the multi-cultural character of 
registered patient data allows to generalize the here-presented results to other 
populations. At present, the Fisher score is still used in clinical routine to estimate the 
risk for DCI. Our results clearly demonstrate that the BNI grading system shows 
advantages as it provides a precise gradual, almost linear prediction of DCI. 
According to the Fisher scale, however, most patients are graded as “Fisher 3”, and 
further sub-stratification of the risk for DCI is not possible. Moreover, the Fisher 
scale, despite its value for the management of aSAH patients over decades, is 
known for weaknesses inherent to interobserver reliability issues.11 
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Compared to the initial publication, our patient cohort included more high-
grade aSAH patients similar to the patient cohort from Dengler et al..8 This explains 
our high overall DCI rate of approximately 30%. The higher amount of patients with 
high-grade aSAH can be explained by the unique setting in Switzerland, where 
tertiary neurovascular centers specialized in aSAH can be reached within a short 
time frame. Therefore, severe aSAH patients will more likely reach specialized 
neurovascular centers for resuscitation, compared to regions with longer time delay 
before hospital admission or interhospital transfer. For this validation study it was 
useful to have this high-grade aSAH patient cohort due to the higher incidence of 
DCI, which further strengthens our results. 
The effect sizes of our validation results were generally lower than the initial 
results from Wilson et al.: Our DCI rates were 25.6 % in BNI grade 2 patients, and 
38.2 % in BNI grade 5 patients with corresponding ORs of 1.9 [1.0 – 3.5, 95 % CI] 
and 3.4 [2.1 – 5.3, 95 % CI], respectively. The original paper from the Barrow 
Neurological Institute reports BNI-grade dependend rates of symptomatic vasospasm 
in the range between 12.5 – 50 %, and corresponding ORs of 1.57 [0.40 – 6.20, 95 
% CI] up to 11.0 [2.27 – 53.37, 95 % CI], respectively.7 The relatively wide CIs of the 
original study indicate that point estimates might have been less accurate. Our 95% 
CIs were much narrower, representing robust estimates of the real effect. For 
example, a patient graded “BNI grade 5” will be 3.4 times as likely as a patient 
graded Fisher 1, 2 or 4 to experience DCI. Based on the large sample size, we are 
95% confident that the real risk lies between 2.1 – 5.3. Dengler et al. also confirmed 
significant prediction of the BNI scale for radiological vasospasm, but showed that 
the effect size is also dependent on the presence of intracranial and intraventricular 
hemorrhage.8 These results summarize that the BNI score is valid to predict DCI, but 
the effect size is not as high as initially reported by Wilson et al..7 
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In the initial manuscript the BNI score was not correlated with clinical 
outcome.7 In our patient cohort we were able to show that the BNI grading system 
may also be used as a predictor for unfavorable clinical outcome (mRS >2). The ORs 
for poor outcome in BNI 5 patients were high with 5.9 [3.9 – 8.9, 95 % CI] at 
discharge and 6.6 [4.1 – 10.5, 95 % CI] at 1FU. These findings are expected, since 
patients with DCI have also a higher risk for unfavorable clinical outcome.12 Similar 
results were presented by Dengler et al. with increasingly unfavorable patient 
outcomes and higher rates of new cerebral infarctions for each increase in BNI 
grade.8 In their analysis, the BNI grade was less relevant for outcome prediction in a 
multivariate analysis compared to patient age and clinical aSAH scores.8 Our 
AUROC analysis confirmed the lower outcome prediction of the BNI score compared 
to the WFNS score (Figure 4), but indicates that discriminative ability for outcome is 
increased if the BNI score is added to the WFNS score. 
 
Strengths and limitations 
 This was an external validation study using prospective, multicenter data from 
various linguistic and cultural areas in Switzerland. The relatively high number of 
cases allowed us to generate robust estimates. However, our study was limited to 
parameters available for analysis based on the Swiss SOS database. The definition 
of vasospasm, symptomatic vasospasm (as used in the original paper), delayed 
ischemic neurological deficit (DIND) and DCI is diverse, but we here used the 
consensus-definition of DCI, representing the current gold standard.10 Unfortunately, 
information on new cerebral infarction attributable to DCI were not available for 
analysis from all centers. The slightly different definition of the primary end-point is 
likely to explain the differences in the effect sizes. Other explanations factoring into 
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this are differences in study population, proportion of high-grade aSAH patients, 
amongst others.   
 
Overall the BNI grading scale outperforms the Fisher scale in predicting DCI 
and may find its role in predicting clinical outcome together with clinical aSAH scores. 
The advantages of the BNI grading score are its simplicity, the better distribution of 
aSAH patients over BNI grades and its linear increase in risk for DCI with higher 
score. The BNI scale appears to be useful for clinical practice, as well as for risk-
stratification in prospective studies testing new therapies to prevent DCI. 
 
 
CONCLUSION 
In this multicenter, external validation analysis from a prospective nationwide 
patient registry we confirmed that patients with higher BNI grades showed gradually 
higher risks for DCI. Besides predicting DCI, the BNI grade was also a predictor for 
unfavorable outcome at discharge and at 1FU. 
 
 
  
 11 
TABLES AND FIGURE LENGENDS 
 
Table 1. Basic patient characteristics and group differences 
 
 all patients 
(n = 1321) 
DCI 
(n = 409) 
no DCI             
(n = 912) 
p-value 
Age (years), 
median (IQR) 
55 (47 - 65) 53 (47 - 62) 55 (47 - 66) 0.046* 
Sex m/f 
(m/f ratio) 
468/853 
(0.55) 
128/281 
(0.46) 
340/572 
(0.59) 
0.040+ 
WFNS grade (%) 
1 
2 
3 
4 
5 
n/a 
 
451 (34.1) 
258 (19.5) 
108 (8.2) 
141 (10.7) 
359 (27.2) 
4 (0.3) 
 
113 (27.6) 
83 (20.3) 
38 (9.3) 
52 (12.7) 
122 (29.8) 
1 (0.2) 
 
338 (37.1) 
175 (19.2) 
70 (7.7) 
89 (9.8) 
237 (26.0) 
3 (0.3) 
 
 
 
0.023‡ 
Fisher grade (%) 
1 
2 
3 
4 
 
40 (3.0) 
87 (6.7) 
1115 (84.4) 
79 (6.0) 
 
1 (0.2) 
16 (3.9) 
377 (92.2) 
15 (3.7) 
 
39 (4.3) 
71 (7.8) 
738 (80.9) 
64 (7.0) 
 
 
<0.001‡ 
 
BNI grade (%) 
1 
2 
3 
4 
5 
 
57 (4.3) 
231 (17.5) 
377 (28.5) 
402 (30.4) 
254 (19.2) 
 
3 (0.7) 
50 (12.2) 
111 (27.1) 
148 (36.2) 
97 (23.7) 
 
54 (5.9) 
181 (19.8) 
266 (29.2) 
251 (27.9) 
157 (17.2) 
 
 
 
<0.001‡ 
 
 
abbreviations: DCI: delayed cerebral ischemia; IQR: interquartile range; WFNS: World Federation of 
Neurosurgical Societies; BNI: Barrow Neurological Institute  
 
* Mann-Whitney-U test; + Chi-Square test; ‡ Fisher`s exact test 
 
 
 
Table 2. Risk of delayed cerebral ischmia (DCI) by BNI Grade and Fisher 
Grade. Fisher grade 3 patients (n=1115) are compared to Fisher grades 1,2 and 4 
(n=206). 
 
Grade No. of patients 
(%) 
DCI 
(%) 
OR for DCI 
(95% CI) 
BNI 1 n/a n/a n/a 
BNI 2 82 (7.4) 21 (25.6) 1.9 (1.0 – 3.5) 
BNI 3 377 (33.8) 111 (29.4) 2.3 (1.5 – 3.5) 
BNI 4 402 (36.1) 148 (36.8) 3.2 (2.1 – 4.9) 
BNI 5 254 (22.8) 97 (38.22) 3.4 (2.1 – 5.3) 
    
Fisher 3 1115 (84.4) 377 (34) 2.8 (1.9 – 4.1) 
Fisher 1,2 and 4 206 (15.6) 32 (16) - 
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Table 3. Risk of poor outcome at discharge (mRS 3-6) by BNI Grade. Outcome data 
was available for 1298 patients. Fisher grade 3 patients (n=1096) are compared to 
Fisher grades 1,2 and 4 (n=202). 
 
Grade No. of patients 
(%) 
Poor outcome  
(%) 
OR  
(95% CI) 
BNI 1 n/a n/a n/a 
BNI 2 82 (7.5) 24 (29.3) 0.8 (0.5 – 1.4) 
BNI 3 374 (34.1) 132 (35.3) 1.1 (0.7 – 1.5) 
BNI 4 393 (35.9) 201 (51.1) 2.1 (1.5 – 2.9) 
BNI 5 247 (22.5) 185 (74.9) 5.9 (3.9 – 8.9) 
 
Table 4. Risk of poor outcome at 1 year follow-up (mRS 3-6) by BNI Grade. Outcome 
data was available for 1119 patients. Fisher grade 3 patients (n=940) are compared 
to Fisher grades 1,2 and 4 (n=179). 
 
Grade No. of patients 
(%) 
Poor outcome  
(%) 
OR  
(95% CI) 
BNI 1 n/a n/a n/a 
BNI 2 72 (7.7) 16 (22.2) 1.4 (0.7 – 2.7) 
BNI 3 334 (35.5) 76 (22.8) 1.4 (0.9 – 2.2) 
BNI 4 318 (33.8) 116 (36.5) 2.7 (1.7 – 4.3) 
BNI 5 216 (23.0) 125 (57.9) 6.6 (4.1 – 10.5) 
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Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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